|
Mechanism50S subunit inhibitors [+2] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with BioAgency AG
0 Patents (Medical) associated with BioAgency AG
100 Deals associated with BioAgency AG
100 Translational Medicine associated with BioAgency AG